The occurrence of GI AEs has led some clinicians to question whether the weight loss observed with semaglutide treatment may be primarily a result of these side effects [52]
DPP-4 inhibitors can also cause several side effects, such as headache, nasopharyngitis, nausea, arterial hypertension, heart failure, pancreatitis and inflammatory bowel disease, and various skin reactions (pruritus, bullous pemphigoid, rash, angioedema and photosensitivity)
Schroll JB, Penninga EI, Gtzsche PC
Wegovy (semaglutide) belongs to a class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1s)
But a more recently filed consumer class action adds a parallel set of allegations to the litigation landscape, reframing the conflict as one that spans patent law, FDA regulation, pharmaceutical manufacturing, and brand positioning in a market that is both commercially dominant and culturally ubiquitous